<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>BioScreening.net &#187; Reagents</title>
	<atom:link href="http://www.bioscreening.net/category/news/reagents/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.bioscreening.net</link>
	<description>BioScreening news and events</description>
	<lastBuildDate>Thu, 29 Dec 2011 08:21:20 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3</generator>
		<item>
		<title>Chemie Uzbekistan 2011</title>
		<link>http://www.bioscreening.net/2011/11/14/chemie-uzbekistan-2011/</link>
		<comments>http://www.bioscreening.net/2011/11/14/chemie-uzbekistan-2011/#comments</comments>
		<pubDate>Mon, 14 Nov 2011 18:18:15 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Agriculture Research]]></category>
		<category><![CDATA[Asia]]></category>
		<category><![CDATA[Equipment & Supplies]]></category>
		<category><![CDATA[Reagents]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1316</guid>
		<description><![CDATA[The 5th Anniversary Central Asian International exhibition «Chemical industry &#8211; Chemie Uzbekistan» and the 2nd Uzbek International exhibition of plastics and rubber &#8211; «Plastex Uzbekistan 2011» will be held from the 16th till the 18th of November 2011, at the Pavilion 1 of OJSS «Uzexpocentre». “ITE UZBEKISTAN” is the organizer of the exhibitions The exhibitions [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/11/14/chemie-uzbekistan-2011/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Galapagos and Merck Serono Enter New Collaboration Agreements</title>
		<link>http://www.bioscreening.net/2008/11/20/galapagos-and-merck-serono-enter-new-collaboration-agreements/</link>
		<comments>http://www.bioscreening.net/2008/11/20/galapagos-and-merck-serono-enter-new-collaboration-agreements/#comments</comments>
		<pubDate>Thu, 20 Nov 2008 20:30:09 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[Compound Libraries]]></category>
		<category><![CDATA[Drug Development]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[News by Region]]></category>
		<category><![CDATA[News by Subject]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Reagents]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/11/20/galapagos-and-merck-serono-enter-new-collaboration-agreements/</guid>
		<description><![CDATA[Mechelen, Belgium; 18 November 2008 â€“ Galapagos NV (Euronext: GLPG) announced today new collaboration agreements with Merck Serono, a division of Merck KGaA, Darmstadt, Germany. Total value of the contracts for Galapagos is â‚¬1.1 million over one year. Galapagosâ€™ service division BioFocus DPI will provide SoftFocusÂ© compounds for use in Merck Seronoâ€™s drug discovery programs. [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/11/20/galapagos-and-merck-serono-enter-new-collaboration-agreements/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>EchoÂ® 520 liquid handler</title>
		<link>http://www.bioscreening.net/2008/02/12/echo%c2%ae-520-liquid-handler/</link>
		<comments>http://www.bioscreening.net/2008/02/12/echo%c2%ae-520-liquid-handler/#comments</comments>
		<pubDate>Wed, 13 Feb 2008 01:59:17 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Reagents]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/02/12/echo%c2%ae-520-liquid-handler/</guid>
		<description><![CDATA[Labcyte announced the introduction of the latest member of its acoustic dispensing family, the EchoÂ® 520 liquid handler, which was developed for the medium-throughput laboratory. The 520 system provides high accuracy and precision transfers of a wide variety of solutions at an appropriate price for the laboratory that needs to transfer as many as 100,000 [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/02/12/echo%c2%ae-520-liquid-handler/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
<enclosure url="http://www.labcyte.com/media/2nL.mpeg" length="2190426" type="video/mpeg" />
		</item>
		<item>
		<title>Gossypol Biological Properties</title>
		<link>http://www.bioscreening.net/2007/10/22/gossypol-biological-properties/</link>
		<comments>http://www.bioscreening.net/2007/10/22/gossypol-biological-properties/#comments</comments>
		<pubDate>Mon, 22 Oct 2007 15:33:01 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cancer Research]]></category>
		<category><![CDATA[HIV Research]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[Natural Products]]></category>
		<category><![CDATA[New Products]]></category>
		<category><![CDATA[Reagents]]></category>
		<category><![CDATA[Veterinary Research]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2007/10/22/gossypol-biological-properties/</guid>
		<description><![CDATA[Gossypol: is a polyphenolic aldehyde that permeates cells and acts as an inhibitor for several dehydrogenase enzymes. is antimalarial being the selective inhibitor of Plasmodium falciparum (pfLDH over hLDHs), an essential enzyme for energy generation within malarial parasite. posesses proapoptotic properties, probably due to the regulation of the Bax and Bcl2. reversibly inhibits Calcineurin and [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2007/10/22/gossypol-biological-properties/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog</title>
		<link>http://www.bioscreening.net/2007/10/18/strategic-diagnostics-launches-initial-oncology-targeted-antibody-reagent-catalog/</link>
		<comments>http://www.bioscreening.net/2007/10/18/strategic-diagnostics-launches-initial-oncology-targeted-antibody-reagent-catalog/#comments</comments>
		<pubDate>Thu, 18 Oct 2007 17:11:33 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cancer Research]]></category>
		<category><![CDATA[Genomics & Pharmacogenomics]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Proteomics]]></category>
		<category><![CDATA[Reagents]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2007/10/18/strategic-diagnostics-launches-initial-oncology-targeted-antibody-reagent-catalog/</guid>
		<description><![CDATA[NEWARK, Del., Oct. 2 /PRNewswire-FirstCall/ &#8212; Strategic Diagnostics Inc. &#8212; today announced the launch of a new internet based catalog of antibody reagents in support of oncology-based research and discovery. These high-quality reagents have all been manufactured utilizing SDI&#8217;s proprietary Genomic Antibody Technology(TM) and will carry the SEQer(TM) brand. The catalog is available at http://antibodies.sdix.com [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2007/10/18/strategic-diagnostics-launches-initial-oncology-targeted-antibody-reagent-catalog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Sigma-Aldrich Introduces N-TER Nanoparticle siRNA Transfection System for Delivery of siRNA Into Difficult-to-Transfect Cell Types</title>
		<link>http://www.bioscreening.net/2007/10/18/sigma-aldrich-introduces-n-ter-nanoparticle-sirna-transfection-system-for-delivery-of-sirna-into-difficult-to-transfect-cell-types/</link>
		<comments>http://www.bioscreening.net/2007/10/18/sigma-aldrich-introduces-n-ter-nanoparticle-sirna-transfection-system-for-delivery-of-sirna-into-difficult-to-transfect-cell-types/#comments</comments>
		<pubDate>Thu, 18 Oct 2007 17:03:07 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[Equipment & Supplies]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Reagents]]></category>
		<category><![CDATA[RNA Reasearch]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2007/10/18/sigma-aldrich-introduces-n-ter-nanoparticle-sirna-transfection-system-for-delivery-of-sirna-into-difficult-to-transfect-cell-types/</guid>
		<description><![CDATA[ST. LOUIS, Oct. 18 /PRNewswire-FirstCall/ &#8212; Sigma-Aldrich announced today the global release of the N-TER(TM) Nanoparticle siRNA Transfection System. N-TER allows researchers to reproducibly interrogate gene function, via siRNA transfection, in model cell types that have previously not been considered amenable to conventional lipid-based siRNA delivery reagents. &#8220;Traditional lipid-based siRNA transfection reagents exhibit a number [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2007/10/18/sigma-aldrich-introduces-n-ter-nanoparticle-sirna-transfection-system-for-delivery-of-sirna-into-difficult-to-transfect-cell-types/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>miRNA QRT-PCR Reagents Kit</title>
		<link>http://www.bioscreening.net/2007/10/18/mirna-qrt-pcr-reagents-kit/</link>
		<comments>http://www.bioscreening.net/2007/10/18/mirna-qrt-pcr-reagents-kit/#comments</comments>
		<pubDate>Thu, 18 Oct 2007 16:59:32 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Reagents]]></category>
		<category><![CDATA[RNA Reasearch]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2007/10/18/mirna-qrt-pcr-reagents-kit/</guid>
		<description><![CDATA[The miRNA QRT-PCR detection kit uses a proprietary miRNA primer design approach to detect mature miRNA from as little as 15 ng of input, down to 100 copies, in less than three hours. Optimized QPCR reagents provide single nucleotide discrimination within and among miRNA families. MicroRNAs (miRNAs) are small, non-coding RNA molecules that are estimated [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2007/10/18/mirna-qrt-pcr-reagents-kit/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Protected: BIT&#8217;s 4th Annual Congress of International Drug Discovery Science &amp; Technology 2006 (IDDST-2006)</title>
		<link>http://www.bioscreening.net/2006/02/15/bits-4th-annual-congress-of-international-drug-discovery-science-technology-2006-iddst-2006/</link>
		<comments>http://www.bioscreening.net/2006/02/15/bits-4th-annual-congress-of-international-drug-discovery-science-technology-2006-iddst-2006/#comments</comments>
		<pubDate>Thu, 16 Feb 2006 03:14:19 +0000</pubDate>
		<dc:creator>iddst2006</dc:creator>
				<category><![CDATA[Africa]]></category>
		<category><![CDATA[Asia]]></category>
		<category><![CDATA[Business and Investment]]></category>
		<category><![CDATA[Cancer Research]]></category>
		<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[Drug-Like Compounds]]></category>
		<category><![CDATA[Education]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Events]]></category>
		<category><![CDATA[HIV Research]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[New Products]]></category>
		<category><![CDATA[News by Subject]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Reagents]]></category>
		<category><![CDATA[South America]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2006/02/15/bits-4th-annual-congress-of-international-drug-discovery-science-technology-2006-iddst-2006/</guid>
		<description><![CDATA[There is no excerpt because this is a protected post.]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2006/02/15/bits-4th-annual-congress-of-international-drug-discovery-science-technology-2006-iddst-2006/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Galapagos Announces Third Quarter 2005 Results</title>
		<link>http://www.bioscreening.net/2005/11/10/galapagos-announces-third-quarter-2005-results/</link>
		<comments>http://www.bioscreening.net/2005/11/10/galapagos-announces-third-quarter-2005-results/#comments</comments>
		<pubDate>Thu, 10 Nov 2005 17:26:10 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Business and Investment]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Mergers and Acquisitions]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Reagents]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2005/11/10/galapagos-announces-third-quarter-2005-results/</guid>
		<description><![CDATA[&#8212; Acquisition of BioFocus completed, integration progresses as planned &#8212; Galapagos year to date revenues 8% below last year&#8217;s revenues, but cash burn in line with forecast &#8212; Revenue guidance for 4Q &#8217;05 of 7.7 million, full year cash burn of 7 million &#8212; Strong cash position of 25 million on Sept. 30, 2005 &#8212; [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2005/11/10/galapagos-announces-third-quarter-2005-results/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharmacopoeial test facility expanded</title>
		<link>http://www.bioscreening.net/2005/11/10/pharmacopoeial-test-facility-expanded/</link>
		<comments>http://www.bioscreening.net/2005/11/10/pharmacopoeial-test-facility-expanded/#comments</comments>
		<pubDate>Thu, 10 Nov 2005 17:24:48 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Europe]]></category>
		<category><![CDATA[Reagents]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2005/11/10/pharmacopoeial-test-facility-expanded/</guid>
		<description><![CDATA[Following interest from its clients, Melbourn Scientific is extending the range of pharmacopoeial testing that it offers. Managing director Steve Westcott says that it is easy to calculate the benefits of outsourcing pharmacopoeial testing: &#8216;Pharmacopoeial testing requires specialist skills, it is the old school chemistry that is taught at few universities because it requires expensive [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2005/11/10/pharmacopoeial-test-facility-expanded/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Research Study Provides Further Evidence of Strong Correlation of TriPath Imaging&#8217;s ProEx C Biomarkers with Biopsy Evidence of High Grade Cervical Intraepithelial Neoplasia (CIN2+)</title>
		<link>http://www.bioscreening.net/2005/11/07/new-research-study-provides-further-evidence-of-strong-correlation-of-tripath-imagings-proex-c-biomarkers-with-biopsy-evidence-of-high-grade-cervical-intraepithelial-neoplasia-cin2/</link>
		<comments>http://www.bioscreening.net/2005/11/07/new-research-study-provides-further-evidence-of-strong-correlation-of-tripath-imagings-proex-c-biomarkers-with-biopsy-evidence-of-high-grade-cervical-intraepithelial-neoplasia-cin2/#comments</comments>
		<pubDate>Mon, 07 Nov 2005 17:28:15 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Reagents]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2005/11/07/new-research-study-provides-further-evidence-of-strong-correlation-of-tripath-imagings-proex-c-biomarkers-with-biopsy-evidence-of-high-grade-cervical-intraepithelial-neoplasia-cin2/</guid>
		<description><![CDATA[In-house and External Retrospective Research Studies Incorporating ProEx C Biomarkers Presented at 53rd Annual Scientific Meeting of the American Society of Cytopathology BURLINGTON, N.C., Nov. 7 /PRNewswire-FirstCall/ &#8212; TriPath Imaging, Inc. (Nasdaq: TPTH) today announced that the results of a new in-house retrospective research study demonstrated that testing of cervical cytology specimens with Research Use [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2005/11/07/new-research-study-provides-further-evidence-of-strong-correlation-of-tripath-imagings-proex-c-biomarkers-with-biopsy-evidence-of-high-grade-cervical-intraepithelial-neoplasia-cin2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Applied Biosystems Introduces New Power SYBR Green Reagents for Real-Time PCR</title>
		<link>http://www.bioscreening.net/2005/10/26/applied-biosystems-introduces-new-power-sybr-green-reagents-for-real-time-pcr/</link>
		<comments>http://www.bioscreening.net/2005/10/26/applied-biosystems-introduces-new-power-sybr-green-reagents-for-real-time-pcr/#comments</comments>
		<pubDate>Wed, 26 Oct 2005 17:21:26 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Reagents]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2005/11/10/applied-biosystems-introduces-new-power-sybr-green-reagents-for-real-time-pcr/</guid>
		<description><![CDATA[Power SYBR Sets a New Standard of Quality and Performance for Real-Time PCR Using SYBR Green Dye FOSTER CITY, Calif. &#038; SALT LAKE CITY&#8211;(BUSINESS WIRE)&#8211;Oct 26, 2005 &#8211; Applied Biosystems (NYSE:ABI), an Applera Corporation business, today announced the launch of Power SYBR(R) Green PCR Master Mix, a new line of reagents for real-time PCR gene [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2005/10/26/applied-biosystems-introduces-new-power-sybr-green-reagents-for-real-time-pcr/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Buffer and reagents as tablets or powders</title>
		<link>http://www.bioscreening.net/2005/10/11/buffer-and-reagents-as-tablets-or-powders/</link>
		<comments>http://www.bioscreening.net/2005/10/11/buffer-and-reagents-as-tablets-or-powders/#comments</comments>
		<pubDate>Tue, 11 Oct 2005 17:26:11 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Europe]]></category>
		<category><![CDATA[Reagents]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2005/10/11/buffer-and-reagents-as-tablets-or-powders/</guid>
		<description><![CDATA[Many users worldwide are already experiencing the advantage of buffers in tablets or pouches. A large variety of buffers and reagents for immunology and microbiology is from now on available through the &#8216;einkaufsinitiative&#8217; life science, a sister company of Tau Competence. The usage of the buffers is very easy: simply dissolve the tablet or pouch [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2005/10/11/buffer-and-reagents-as-tablets-or-powders/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

